サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629873

呼吸ケア機器の世界市場（2025年～2033年）

Global Respiratory Care Devices Market - 2025-2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
呼吸ケア機器の世界市場（2025年～2033年）
出版日: 2024年12月30日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

呼吸ケア機器の世界市場は、2023年に228億5,000万米ドルに達し、2033年には405億9,000万米ドルに達すると予測され、予測期間2025年にはCAGR 6.4%で成長すると予測されています。

呼吸ケア機器は、呼吸困難や肺関連疾患の患者の呼吸機能をサポートし、改善するために使用される医療機器です。喘息、COPD、睡眠時無呼吸症候群、ARDSなどの呼吸器疾患の予防、診断、モニタリング、治療に使用されます。主な種類には、人工呼吸器のような治療用機器、スパイロメーターのような診断用機器、パルスオキシメーターのような監視用機器があります。これらの機器は、患者の転帰と生活の質を改善するために、病院、診療所、在宅医療の現場で広く使用されています。

市場力学：

促進要因と抑制要因

呼吸器疾患の有病率の上昇

世界の呼吸ケア機器市場は、COPD、喘息、睡眠時無呼吸症候群、急性感染症などの呼吸器疾患の増加によって牽引されています。大気汚染、喫煙、高齢化などの要因がこれらの疾患の原因となっています。これらの疾患には長期的な管理と高度な医療サポートが必要です。COVID-19の大流行は、急性呼吸困難の管理における呼吸ケア機器の重要性を浮き彫りにし、意識の向上と投資の増加につながりました。呼吸器疾患の負担増は、ポータブルで使いやすい機器の技術革新を促し、在宅ケアの動向に対応しています。この普及は市場の成長を加速させ、世界的にアクセスしやすく、効率的で手頃な価格の呼吸ケアソリューションの必要性を強調しています。

例えば、NCD Allianceによると、慢性呼吸器疾患（CRDs）は肺に関連する疾患で、世界中で重大な罹患率と死亡率を引き起こしています。一般的なCRDには、COPD、喘息、肺がん、職業性肺疾患などがあります。これらの疾患は、全世界で少なくとも5,500億人の成人が罹患しており、全死亡の7％を占めています。肺がんはさらに年間14億人の死亡の原因となっています。肺炎のような急性感染症や喘息のような慢性疾患を含め、5歳未満の子どもは特に肺疾患の影響を受けています。喘息は最も一般的な慢性疾患であり、全世界の子どもの14％が罹患しています。CRDsの有病率は1990年から2017年の間に40％増加していますが、他のNCDsに比べて注目度は低いです。

機器操作の複雑さ

世界の呼吸ケア機器市場は、特に人工呼吸器、CPAP装置、酸素濃縮器などの高度な装置など、装置操作の複雑さによる大きな抑制要因に直面しています。これらの機器は、適切なセットアップ、使用方法、メンテナンスのために専門的な知識を必要としますが、ヘルスケア専門家、介護者、在宅ケア環境の患者に対するトレーニングが不十分なため、困難な課題となっています。

この課題は、ヘルスケアの専門家が専門知識に乏しく、在宅医療の現場でも適切なサポートが得られないことが多い低資源地域ではより顕著です。モニタリングとキャリブレーションが常に必要であることも複雑さに拍車をかけ、機器の最適な機能を確保するためには熟練した労働力が必要となります。このような運用上の困難は、特にサービスが行き届いていない地域での呼吸ケア機器の採用を阻害し、市場の成長可能性を制限する可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 呼吸器疾患の罹患率の上昇
    • 抑制要因
      • デバイス操作の複雑さ
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 製品タイプ別

  • 治療機器
    • 持続陽圧呼吸療法（CPAP）装置
    • 二相性陽圧呼吸装置（BiPAP）
    • 人工呼吸器
    • ネブライザー
    • 吸入器（定量吸入器、ドライパウダー吸入器）
    • 酸素濃縮器
  • 監視デバイス
    • パルスオキシメーター
    • カプノグラフ
    • ガス分析装置
  • 診断装置
    • スパイロメーター
    • 睡眠ポリグラフ装置
    • ピークフローメーター
  • 消耗品および付属品
    • 呼吸回路
    • 鼻カニューレ
    • マスク
    • チューブ
    • フィルター

第7章 用途別

  • 慢性閉塞性肺疾患（COPD）
  • 喘息
  • 閉塞性睡眠時無呼吸症候群（OSA）
  • 呼吸窮迫症候群
  • その他

第8章 エンドユーザー別

  • 病院・クリニック
  • 在宅ケア
  • 外来手術センター

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第10章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第11章 企業プロファイル

  • Philips Respironics（Philips Healthcare）
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
  • ResMed Inc.
  • Medtronic Plc
  • Fisher & Paykel Healthcare
  • Invacare Corporation
  • Dragerwerk AG & Co. KGaA
  • GE Healthcare
  • Getinge AB
  • Teleflex Incorporated
  • Hamilton Medical AG

第12章 付録

目次
Product Code: MD8903

The global respiratory care devices market reached US$ 22.85 billion in 2023 and is expected to reach US$ 40.59 billion by 2033, growing at a CAGR of 6.4% during the forecast period 2025-2033.

Respiratory care devices are medical equipment used to support and improve the respiratory functions of patients with breathing difficulties or lung-related conditions. They are used for the prevention, diagnosis, monitoring, and treatment of respiratory disorders like asthma, COPD, sleep apnea, and ARDS. Key types include therapeutic devices like ventilators, diagnostic tools like spirometers, and monitoring devices like pulse oximeters. These devices are widely used in hospitals, clinics, and home care settings to improve patient outcomes and quality of life.

Market Dynamics: Drivers & Restraints

Rise in the Prevalence of Respiratory Diseases

The global respiratory care devices market is driven by the rise in respiratory diseases like COPD, asthma, sleep apnea, and acute infections. Factors like air pollution, smoking, and aging populations contribute to these conditions. Long-term management and advanced medical support are needed for these diseases. The COVID-19 pandemic highlighted the importance of respiratory care devices in managing acute respiratory distress, leading to increased awareness and investment. The rising burden of respiratory diseases has encouraged innovation in portable, user-friendly devices, catering to home-based care trends. This prevalence accelerates market growth and emphasizes the need for accessible, efficient, and affordable respiratory care solutions globally.

For instance, according to NCD Alliance, Chronic respiratory diseases (CRDs) are lung-related diseases that cause significant morbidity and mortality worldwide. Common CRDs include COPD, asthma, lung cancer, and occupational lung diseases. These diseases affect at least 550 Billion adults globally and account for 7% of all deaths. Lung cancer contributes to another 1.4 Billion deaths annually. Children under five years of age are particularly affected by lung diseases, including acute infectious diseases like pneumonia and chronic conditions like asthma. Asthma is the most common chronic condition, affecting 14% of children globally. The prevalence of CRDs has increased by 40% between 1990 and 2017, but they have received less attention than other NCDs.

Complexity of Device Operation

The global respiratory care devices market faces significant restraint due to the complexity of device operation, especially advanced devices like ventilators, CPAP machines, and oxygen concentrators. These devices require specialized knowledge for proper setup, usage, and maintenance, which can be challenging due to inadequate training for healthcare professionals, caregivers, and patients in home care settings.

This challenge is more pronounced in low-resource regions where healthcare professionals may lack expertise, and home healthcare settings often lack proper support. The constant need for monitoring and calibration adds to the complexity, requiring a skilled workforce to ensure optimal device functionality. These operational difficulties can discourage the adoption of respiratory care devices, especially in underserved areas, limiting the market's growth potential.

Segment Analysis

The global respiratory care devices market is segmented based on product type, application, end user and region.

Product type:

Therapeutic Devices segment is expected to dominate the respiratory care devices market share

The therapeutic devices segment holds a major portion of the respiratory care devices market share and is expected to continue to hold a significant portion of the respiratory care devices market share during the forecast period.

Therapeutic devices are crucial in managing chronic and acute respiratory conditions, such as COPD, asthma, sleep apnea, and respiratory distress syndrome. The global respiratory care devices market is growing due to factors like air pollution, smoking, and aging populations. Technological advancements, such as portable oxygen concentrators and smart CPAP machines, have enhanced patient convenience and compliance. The COVID-19 pandemic highlighted the importance of ventilators and oxygen therapy, leading to increased awareness and investment in therapeutic devices. The trend towards home-based care and reducing healthcare costs has driven the adoption of these devices, ensuring long-term management of respiratory diseases outside traditional healthcare settings.

For instance, in September 2024, ResMed has launched its AirTouch N30i continuous positive airway pressure (CPAP) mask, designed to provide a comfortable sleep experience for users with sleep apnea. The mask features a fabric-wrapped frame and a soft, breathable, moisture-wicking design for optimal comfort. It builds upon ResMed's previous masks to combine softness, breathability, and a high-performance seal, making it easier for people to start and stick with CPAP therapy.

Moreover, in February 2024, ResMed has introduced its AirCurve 11 series, a bilevel device that uses inspiratory and expiratory positive airway pressure (IPAP) to treat sleep apnea. The AirCurve 11 VAuto is a bilevel PAP that provides higher pressure during inhalation and lower pressure during exhalation, allowing the device to align more closely with natural breathing patterns.

Application:

Chronic Obstructive Pulmonary Disease (COPD) segment is the fastest-growing segment in respiratory care devices market share

The Chronic Obstructive Pulmonary Disease (COPD) segment is the fastest-growing segment in the respiratory care devices market share and is expected to hold the market share over the forecast period.

Chronic Obstructive Pulmonary Disease (COPD) is a major global health concern, causing significant morbidity and mortality. The condition, primarily caused by smoking, air pollution, occupational hazards, and genetic factors, has led to a surge in demand for respiratory care devices like oxygen concentrators, nebulizers, and ventilators. These devices are crucial for managing symptoms, improving oxygenation, and enhancing patient quality of life. The growing awareness of early diagnosis and treatment, coupled with technological advancements, has fueled the adoption of portable and home-based solutions for COPD management. The economic burden of hospitalizations due to severe COPD exacerbations has shifted focus towards preventive and long-term care, driving market expansion globally.

For instance, in March 2023, Pulmonologists at the University of Cincinnati have developed a new breathing device called PEP Buddy, which not only improves breathlessness and quality of life for COPD patients but also benefits those dealing with stress and anxiety, as well as those practicing mindfulness, meditation, or yoga. The device, created by Muhammad Ahsan Zafar and Ralph Panos, was published in the journal Respiratory Care. Zafar is an associate professor in the Department of Pulmonary Critical Care and Sleep Medicine, Panos is a professor emeritus in pulmonary and critical care.

Geographical Analysis

North America is expected to hold a significant position in the respiratory care devices market share

North America holds a substantial position in the respiratory care devices market and is expected to hold most of the market share due to the novel product launches, high prevalence of chronic diseases like COPD, asthma, and sleep apnea, driven by lifestyle factors and an aging population. The region's healthcare infrastructure supports the widespread use of advanced respiratory care devices, such as ventilators, nebulizers, and CPAP machines. Government and private insurance programs offer favorable reimbursement policies, reducing financial burdens and enabling broader access. The region is also a hub for innovation, with companies investing in portable, wireless, and AI-powered devices for home-based care.

For instance, in December 2024, University Medical Devices (UMD) has launched its first specimen collection method, MicroWash, a comfortable and sensitive nasal lavage device designed as a less invasive alternative to nasal swabs during the COVID-19 pandemic.

Moreover, in July 2023, Emerson has introduced the ASCO Series 588 Stationary Oxygen Concentrator Manifold, a turnkey solution for the healthcare industry. This manifold optimizes respiratory therapy device designs, accelerates product speed to market, and improves energy efficiency, lifespan, and reliability of oxygen concentrators, ensuring they are readily available and reliable for patients.

Europe is growing at the fastest pace in the respiratory care devices market

Europe holds the fastest pace in the respiratory care devices market and is expected to hold most of the market share due to the aging population, environmental factors, and the healthcare system's focus on early diagnosis and treatment. The adoption of novel advanced respiratory care devices is encouraged by reimbursement frameworks and the growing trend towards home-based care solutions. Countries like Germany, France, and the UK drive innovation and market growth due to their strong clinical research capabilities and supportive regulatory environments.

For instance, in October 2024, Chiesi UK and Ireland and Health Innovation Manchester have launched the iMprovIng outcomes in respiratory care Greater Manchester (MISSON) project, which will introduce clinically-validated LungHealth software to up to 150 GP practices in Greater Manchester over a two-year period. The software uses digital technology, embedded algorithms, and patient medical records to provide computer-guided consultations for asthma and COPD annual reviews.

Moreover, in October 2024, The LungHealth software, developed by Health Innovation Manchester and Chiesi UK and Ireland, is being introduced to 150 GP practices in Greater Manchester over a two-year period. The software uses embedded algorithms and patients' medical records to provide computer-guided consultations for asthma and COPD annual reviews. The software can be carried out remotely or face-to-face, and also provides clinical prompts to upskill healthcare professionals. The MISSION project aims to evaluate the technology's effectiveness in improving the quality, effectiveness, and consistency of reviews, thereby reducing the impact of asthma and COPD exacerbations on patients and the NHS.

Competitive Landscape

The major global players in the respiratory care devices market include Koninklijke Philips N.V.; Fitbit (Google); Garmin Ltd.; Medtronic; Omron; Withings; VitalConnect; Polar Electro; Sotera, Inc.; INVIZA Corporation; Dexcom, Inc.; GE HealthCare; CONTEC MEDICAL SYSTEMS CO., LTD; Nanowear Inc. among others.

Emerging Players

The emerging players in the respiratory care devices market include Vivos Therapeutics, Omron Healthcare, AirSep Corporation and among others.

Key Developments

  • In February 2024, Getinge, a global medical technology leader, has introduced the Servo-c mechanical ventilator, a revolutionary device designed to address the diverse respiratory needs of patients in India, both pediatric and adult. The ventilator is designed to provide lung-protective therapeutic tools, catering to the evolving healthcare landscape. Getinge aims to empower hospitals with advanced healthcare solutions without compromising on quality, focusing on accessibility and affordability.
  • In March 2023, Vitalograph, a respiratory diagnostic device developer, has launched its VitaloPFT Pulmonary Function Testing Series for secondary care use. The launch took place at the Arab Health Exhibition in Dubai, supported by Irish minister for trade promotion and digital transformation Dara Calleary TD and Irish ambassador Alison Milton. The VitaloPFT Series provides advanced respiratory diagnostic solutions for hospitals and other secondary care units requiring complex pulmonary function testing.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global respiratory care devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Respiratory Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. Complexity of Device Operation
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 6.1.2. Market Attractiveness Index, By Product type
  • 6.2. Therapeutic Devices*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Continuous Positive Airway Pressure (CPAP) Devices
    • 6.2.4. Bi-level Positive Airway Pressure (BiPAP) Devices
    • 6.2.5. Ventilators
    • 6.2.6. Nebulizers
    • 6.2.7. Inhalers (Metered-Dose Inhalers, Dry Powder Inhalers)
    • 6.2.8. Oxygen Concentrators
  • 6.3. Monitoring Devices
    • 6.3.1. Pulse Oximeters
    • 6.3.2. Capnographs
    • 6.3.3. Gas Analyzers
  • 6.4. Diagnostic Devices
    • 6.4.1. Spirometers
    • 6.4.2. Polysomnography Devices
    • 6.4.3. Peak Flow Meters
  • 6.5. Consumables and Accessories
    • 6.5.1. Breathing Circuits
    • 6.5.2. Nasal Cannulas
    • 6.5.3. Masks
    • 6.5.4. Tubes
    • 6.5.5. Filters

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Chronic Obstructive Pulmonary Disease (COPD)*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Asthma
  • 7.4. Obstructive Sleep Apnea (OSA)
  • 7.5. Respiratory Distress Syndrome
  • 7.6. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals & Clinics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Home Care Settings
  • 8.4. Ambulatory Surgical Centers

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Philips Respironics (Philips Healthcare)*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. ResMed Inc.
  • 11.3. Medtronic Plc
  • 11.4. Fisher & Paykel Healthcare
  • 11.5. Invacare Corporation
  • 11.6. Dragerwerk AG & Co. KGaA
  • 11.7. GE Healthcare
  • 11.8. Getinge AB
  • 11.9. Teleflex Incorporated
  • 11.10. Hamilton Medical AG

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us